What the Government's Latest Social Care Reform Update Means for Families Choosing Care at Home

The government has published its latest update on adult social care reform, responding to recommendations from Baroness Casey's Independent Commission on Adult Social Care. There's a lot in it, but a few points stood out to me as genuinely relevant if you're a family currently weighing up care options for a loved one — particularly anything to do with dementia.

What the Government Has Announced

Caption to confirm against actual image content

The update, published 22 June, covers three areas: a new national safeguarding board, a significant package of dementia commitments, and faster support for people with motor neurone disease (MND). None of this changes anything overnight, but it gives a clear sense of direction for where social care policy is heading over the next year.

Who Is Baroness Casey, and Why Does This Letter Matter?

Baroness Louise Casey leads the Independent Commission on Adult Social Care, which launched in April 2025 with a brief to recommend long-term reform of the sector. Her work is being delivered in two phases — a first report due later this year, and a final report in 2028.

Back in March, in a speech that drew a lot of attention across the sector, she described social care as a system that had "never had its own creation moment," unlike the NHS, and called for a national reckoning on the scale of the 1948 NHS reforms. Alongside that speech, she wrote to the Health Secretary asking for six immediate actions on safeguarding, dementia and MND, given the urgency of the issues involved. This letter is the government's formal update on progress against those six asks — which is why it's worth paying attention to, even before her full report lands.

A New National Safeguarding Board

A new national adult safeguarding board has been set up, chaired by the Chief Social Worker and reporting directly to the Minister of State for Care. It's been given a fairly specific set of early priorities: updating statutory guidance on adult safeguarding under the Care Act, covering areas like homelessness, drugs and alcohol, and transitional safeguarding for young adults; an urgent review of whether the legal framework for safeguarding is robust enough to respond to serious risks; and a look at how safeguarding concerns currently get escalated from a local to a national level, since that's been identified as a weak point.

For families, the headline is simpler: there's now meant to be a single national body with oversight of how vulnerable adults are protected, rather than safeguarding being managed purely at a local level with little national visibility of patterns or failures.

Dementia Support: A New Framework and a "Dementia Tsar"

This is the section with the most substance. The government has committed to publishing a new modern service framework for dementia and frailty by the end of the year — described as an outcome-led blueprint covering faster access to diagnosis and treatment. Alongside it, a new "dementia tsar" will be appointed to drive progress across the system, with recruitment due to begin shortly.

There's also a clear research push behind this. The government has adopted a target to scale UK dementia trial participation to 2,000 people within five years, up from 377 in the last year — a significant jump. That's being backed by investment in diagnostic research, increased funding for an existing trial (AD-SMART), and the next phase of something called the Dementia Trials Accelerator, aimed at building the infrastructure needed to run more trials, in more places, more quickly.

New Hope on Alzheimer's Drugs: The NICE Decision in July

One date worth knowing: 8 July. That's when NICE, the body that decides which treatments the NHS funds, holds a committee meeting to consider two newer Alzheimer's treatments, lecanemab and donanemab. Both are a different type of drug to older Alzheimer's medications — they work by targeting and clearing a protein called amyloid in the brain, and trial data has shown they can slow the rate of cognitive decline in people with early-stage Alzheimer's disease, rather than just managing symptoms.

Baroness Casey had recommended piloting access to both drugs via something called the ACCESS-AD consortium. The government's letter confirms it will finalise its approach once NICE has met. It's a genuinely significant decision to watch, even though it's specific to early-stage Alzheimer's rather than dementia more broadly.

What "Living Well in Your Own Neighbourhood" Could Mean for Families

Caption to confirm against actual image content

The line that stood out to me most was the commitment to ensure people have "the right access to support that allows them to live well in their own neighbourhoods." It's a small phrase, but it matters — it's a recognition that good dementia care doesn't always mean a move into residential care. For a lot of families, staying at home with the right support, for as long as that remains the safest and best option, is exactly what they want. It's too early to say precisely what this will mean in practice, but it's a direction worth watching.

How the Sector Has Responded

The response from charities and care organisations has been a mix of welcome and caution, which is probably a fair reflection of where things stand. Alzheimer's Society described the new dementia tsar role as "an important step," while Alzheimer's Research UK has been blunter, pointing out that dementia is the UK's leading cause of death and arguing that every year of delay in prioritising it "costs lives and costs the UK billions." On the more cautious side, the Association of Directors of Adult Social Services has noted that even with high-profile conditions like MND, there are still major gaps in how health and care services join up in practice — a reminder that announcements and delivery aren't the same thing.

Faster Support for People with Motor Neurone Disease

The update also commits to faster, better-coordinated care for people with MND, including fast-tracked access to support, multidisciplinary working between teams in line with MND Association guidance, anticipating future needs as the condition progresses, and a review of housing assistance — including whether means testing on Disabled Facilities Grants should be waived for people with MND. A full prototype fast-track pathway is being developed with local authorities, the NHS, housing bodies and the MND Association, and will be tested and refined before wider rollout.

What This Means If You're Choosing Care for a Loved One Now

Most of what's been announced — the dementia framework, the tsar, the NICE decision — is still to come, so it's sensible to treat this as a direction of travel rather than something that changes care decisions today. What it does signal clearly is that dementia care, and the principle of supporting people to stay independent in their own homes and communities for as long as possible, is becoming a more visible national priority rather than an afterthought.

If you're currently weighing up care options for a loved one, that's a reasonable thing to factor into longer-term thinking, even if the immediate choices in front of you — home care, live-in care, or a move into residential care — stay much the same for now. The fundamentals of good care don't change while we wait for policy to catch up: the right support, consistently delivered, by people who understand the person they're caring for.

Talk to Us About Care at Home

If you're thinking through care options for a loved one — whether that's support to stay at home, or finding the right residential care home — we're happy to talk it through.